Mouchsiadis Ntemis* and Chatzigeorgiou Charalampos
Department of Reumatology, First General Hospital of Thessaloniki
*Corresponding Author: Mouchsiadis Ntemis, Department of Reumatology, First General Hospital of Thessaloniki
Received: December 18, 2021; Published: January 06, 2022
WHO declared SARS-CoV-2 in 2019 a global pandemic. The present aim was to show the prevalence of vitamin D in patients in Greece via real-life data and observation and to compare it with mean levels of vitamin D of general population of same age group.
Methodology: We studied 368 patients with Sars-CoV-2 infection who had been treated in GHT<Ayios Pavlos> during periods (November 2020-February 2021 and November 2021). The mean age was 55 years old (±5). The study ensured the patients' anonymity and was performed in accordance with the national legislation on the use of clinical data for research purposes. In our study, serum 25-(OH) D was measured using the Elecsys® Vitamin D Assay, an electrochemiluminescence binding assay (ECLIA) for the in-vitro determination of total 25-(OH)D (Roche).
Result: Despite Greece is the one of the sunniest countries in Europe there is a paradox, so called Mediterranean, with low mean levels of vitamin D (= 25.08 ng/ml or 62.4 nmol/L) .
Keywords: COVID-19; SARS-CoV2; Vitamin D; Calcitriol
Citation: Mouchsiadis Ntemis and Chatzigeorgiou Charalampos. “Statistical Data from Real-life Observation of Vitamin D Level in Patients in Greece with SARS-CoV-2 Infection". Acta Scientific Clinical Case Reports 3.2 (2022): 03-05.
Copyright: © 2022 Mouchsiadis Ntemis and Chatzigeorgiou Charalampos. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.